Medicated or not medicated hypnotic substance use: strategies in sleep disorders among patients of community pharmacy.

Autor: Lauzeille D; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France., Guerlais M; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France., Sallenave-Namont C; Pharmacy Faculty, UFR Sciences Pharmaceutiques et Biologiques, 9 rue Bias BP 61112 44035, Nantes cedex 1, France., Etcheverrigaray F; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France., Broccato L; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France., Poisblaud Q; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France., Jolliet P; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France.; UMR INSERM 1246 - SPHERE, 'MethodS in Patients-centered outcomes and HEalth ResEarch', Institut de recherche en Santé 2, 22 boulevard Benoni-Goullin, 44200 Nantes, France., Victorri-Vigneau C; Pharmacology department, Centre d'Evaluation et d'Information sur la Pharmacodépendance - Addictovigilance (CEIP-A), Institut de Biologie, 9 quai Moncousu, 44093 Nantes cedex 01, France.; UMR INSERM 1246 - SPHERE, 'MethodS in Patients-centered outcomes and HEalth ResEarch', Institut de recherche en Santé 2, 22 boulevard Benoni-Goullin, 44200 Nantes, France.
Jazyk: angličtina
Zdroj: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2019 Apr; Vol. 33 (2), pp. 216-222. Date of Electronic Publication: 2018 Nov 21.
DOI: 10.1111/fcp.12420
Abstrakt: The principal outcome was to identify which hypnotics substances, medicated (benzodiazepines, antihistamine, antidepressant…) or not medicated (herbal medicine, homeopathy, melatonin…), were consumed by community pharmacy patients who reported taking something for sleep disorder, and which factors can influence the consumption of medicated substance rather than nonmedicated substance. Data were collected via a network of 73 partner pharmacies around Nantes, France. Patients who reported taking a substance to sleep completed a questionnaire that collected data relative to the different substances consumed by that person for sleep, and the desired effect. Substances were classified in Hypnotic Drug Substances and nonmedicated hypnotic substances. A logistical regression was done in order to highlight the factors associated with the consumption of Hypnotic Drug Substance rather than nonmedicated hypnotic substances. Six hundred and forty-seven patients were included, with an average age of 58 years and 74% female. The principal strategy employed to combat sleep disorder was the consumption of Hypnotic Drug Substance (54%), followed by herbal medicine (32%) and homeopathy (19%). The factors positively associated with the consumption of a Hypnotic Drug Substance are age, living alone, being out of work, or in the process of looking for a job and being a parent. In our survey, the use of Hypnotic Drug Substance to help patients with sleep is far from systematic. On the other hand, among patients who consume HDS, misuse is still significant, particularly in terms of the duration of consumption.
(© 2018 Société Française de Pharmacologie et de Thérapeutique.)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje